Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Tompkins

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|March 20, 2001
Phenylacetate pharmacokinetics based on iterative two-stage population analysisA H Burstein, E Reed, A C Tompkins, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Suramin-induced neutropeniaN A Dawson, R M Lush, S M Steinberg, et al.
Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.
Cancer Research|April 1, 1994
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancerA Thibault, M R Cooper, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|March 20, 2001
Phenylacetate pharmacokinetics based on iterative two-stage population analysisA H Burstein, E Reed, A C Tompkins, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Suramin-induced neutropeniaN A Dawson, R M Lush, S M Steinberg, et al.
Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.
Cancer Research|April 1, 1994
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancerA Thibault, M R Cooper, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.
Pageof 1